Search
Search Results
-
Cost-utility analysis of genomic profiling in early breast cancer in Colombia
BackgroundIn Colombia, the best strategy to establish indication for adjuvant chemotherapy in early breast cancer (EBC) remains unknown. This study...
-
Cost-utility and cost-effectiveness analysis of disease-modifying drugs of relapsing–remitting multiple sclerosis: a systematic review
BackgroundMultiple sclerosis (MS) is a chronic, autoimmune, and inflammatory disease. The economic burden of MS is substantial, and the high cost of...
-
Cost-utility analysis of different venous access devices in breast cancer patients: a decision-based analysis model
BackgroundVenous access devices commonly used in clinical practice for long-term chemotherapy of breast cancer include central venous catheters...
-
Cost–utility analysis of using high-intensity statin among post-hospitalized acute coronary syndrome patients
BackgroundPost-hospitalized acute coronary syndrome (ACS) patients in Indonesia National Insurance does not pay for the use of high-intensity statin...
-
Cost-utility analysis of prenatal diagnosis of congenital cardiac diseases using deep learning
BackgroundDeep learning (DL) is a new technology that can assist prenatal ultrasound (US) in the detection of congenital heart disease (CHD) at the...
-
Rationing in an Era of Multiple Tight Constraints: Is Cost-Utility Analysis Still Fit for Purpose?
Cost-utility analysis may not be sufficient to support reimbursement decisions when the assessed health intervention requires a large proportion of...
-
Cost-utility analysis of treating mild stage normal tension glaucoma by surgery in China: a decision-analytic Markov model
BackgroundMany individuals suffer from normal tension glaucoma (NTG) in China. This study utilized Markov models to evaluate the cost-utility of...
-
Cost-utility analysis of add-on vericiguat for the treatment of chronic heart failure with reduced ejection fraction in China
ObjectiveThis study aimed to evaluate the cost-utility of the addition of vericiguat for treating chronic heart failure (CHF) in China from the...
-
Cost-effectiveness analysis of bevacizumab for cerebral radiation necrosis treatment based on real-world utility value in China
BackgroundBevacizumab shows superior efficacy in cerebral radiation necrosis (CRN) therapy, but its economic burden remains heavy due to the high...
-
Cost–Utility Analysis of Prostatic Artery Embolization for Treatment of Lower Urinary Tract Symptoms
PurposeTo perform a post hoc cost–utility analysis of a randomized controlled clinical trial comparing prostatic artery embolization (PAE) and...
-
Cost–utility analysis of trastuzumab deruxtecan versus trastuzumab emtansine in HER2-positive metastatic breast cancer in Chinese setting
PurposeTrastuzumab deruxtecan (T-DXd) expressed substantial improvement in the progression-free survival and overall survival contrasted with...
-
Cost–Utility Analysis of Vericiguat in Heart Failure with Reduced Ejection Fraction After Worsening Heart Failure Events in China
ObjectiveVericiguat is a new medication to demonstrate clinical efficacy in heart failure with reduced ejection fraction (HFrEF) after worsening...
-
Worked Example in Cost-Utility Analysis
This chapter builds upon the previous ones and provides a detailed description of the individual steps involved in designing a protocol for a...
-
Cost-utility analysis of transitional care services for older inpatients with chronic obstructive pulmonary disease (COPD) in Korea
BackgroundChronic obstructive pulmonary disease (COPD) is associated with a high readmission rate and poses a significant disease burden. South Korea...
-
Cost-utility analysis of valsartan, enalapril, and candesartan in patients with heart failure in Iran
BackgroundToday, heart failure is one of the leading causes of death and disability in most developed and developing countries. By 2030, more than...
-
Cost-effectiveness and cost-utility of a digital technology-driven hierarchical healthcare screening pattern in China
Utilization of digital technologies for cataract screening in primary care is a potential solution for addressing the dilemma between the growing...
-
Cost-utility analysis of pharmacogenomics-guided tacrolimus treatment in Austrian kidney transplant recipients participating in the U-PGx PREPARE study
Chronic kidney disease (CKD) is a global health issue. Kidney failure patients may undergo a kidney transplantation (KTX) and prescribed an...
-
Cost Effectiveness of Rituximab Therapy for Rheumatoid Arthritis: A Systematic Review and Meta-Analysis of Cost-Utility Studies
Background and ObjectivesDepletion of B cells is shown to be clinically effective for rheumatoid arthritis (RA) treatment. Although B-cell depletion...
-
Cost-utility analysis of the UPRIGHT intervention promoting resilience in adolescents
BackgroundAs mental health in adulthood is related to mental status during adolescence, school-based interventions have been proposed to improve...
-
A Trial-Based Cost-Utility Analysis of a Medication Optimization Intervention Versus Standard Care in Older Adults
BackgroundOlder adults are at greater risk of medication-related harm than younger adults. The Integrated Medication Management model is an...
